Cancer Medicine

Papers
(The H4-Index of Cancer Medicine is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Molecular profiling of colorectal cancer in a genetically admixed Hispanic population414
Racial and ethnic disparities in mortality among World Trade Center Health Registry enrollees with post‐9/11 cancer247
Issue Information157
Effects of FABP5 Expression on Clinicopathological and Survival Characteristics in Digestive System Malignancies: A Systematic Review and Meta‐Analysis126
Impact of Body Image Perception on Behavioral Outcomes in Chinese Adolescent and Young Adult Survivors of Sarcoma100
Issue Information99
Physical Activity Patterns According to Demographic, Social, and Clinical Correlates Among Breast Cancer Survivors97
Oil blotting paper for formalin fixation increases endoscopic ultrasound‐guided tissue acquisition‐collected sample volumes on glass slides90
Safety and efficacy of fruquintinib‐based therapy in patients with advanced or metastatic sarcoma89
88
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion78
Deficiency of SR‐B1 reduced the tumor load of colitis‐induced or APCmin/+‐induced colorectal cancer74
Association of various RAS codon mutations and prognostic outcomes of patients with colorectal liver metastases after hepatectomy72
Inflammatory geriatric nutritional risk index stratified the survival of older adults with cancer sarcopenia72
Distinct Clinicopathological Features of HER2 ‐Negative, HER2 ‐Low, and H61
Effect modification of age and hypertension on cancer and prevalence of self‐reported stroke – A cross‐sectional study60
Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET‐amplified gastric cancer59
Cost‐effectiveness analysis of tumor‐infiltrating lymphocytes biomarkers guiding chemotherapy de‐escalation in early triple‐negative breast cancer59
Family physicians' involvement in palliative cancer care57
Outcomes and risk factors of SARS‐CoV‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy57
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)57
Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy55
Social Determinants of Health Predict Sleep–Wake Disturbances Among Patients Living With Primary Brain Tumors: A Cross‐Sectional Analysis55
Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database54
Up‐regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy52
Impact of race/ethnicity and language preferences on pediatric ALL survival outcomes50
MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements50
49
Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real‐World Impact of Ca49
Immune‐check blocking combination multiple cytokines shown curative potential in mice tumor model48
Impacts and Pathways of Behavioral Activation on Psychological Distress Among Patients Diagnosed With Esophageal and Gastric Cancer in China: A Randomized Controlled Trial48
An online randomised controlled trial of prognosticating imminent death in advanced cancer patients: Clinicians give greater weight to advice from a prognostic algorithm than from another clinician wi48
Efficacy and safety of irinotecan combined with raltitrexed or irinotecan monotherapy for salvage chemotherapy of esophageal squamous cell cancer: A prospective, open label, randomized phase II47
Predicting cervical lymph node metastasis in OSCC based on computed tomography imaging genomics47
Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M‐positive non‐small cell lung cancer46
Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations46
Predicting Neoplastic Polyp in Patients With Gallbladder Polyps Using Interpretable Machine Learning Models: Retrospective Cohort Study46
Improved Chemosensitivity in Metastatic Castration‐Resistant Prostate Cancer: The Synergistic Effects of S‐Adenosylmethionine and Cabazitaxel45
Linking Targeted Pancreatic Cancer Genes With Metabolic Disorders: A Cross‐Species Translational Pathway45
Correction to “Characterization of Cancer Survivors Clustered by Subjective and Objective Cognitive Function Scores”45
Associations of the Colon Tissue Microbiome and Circulating Bile Acids With Colorectal Adenoma Among Average‐Risk Women44
Machine Learning–Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity43
Effect of electronic health (eHealth) on quality of life in women with breast cancer: A systematic review and meta‐analysis of randomized controlled trials43
0.080093860626221